Adrian Senderowicz Joins Constellation Pharma as Chief Medical Officer

Constellation Pharmaceuticals has appointed Adrian Senderowicz senior vice president and chief medical officer. Before joining Constellation, a Cambridge, MA-based cancer immunotherapy developer, Senderowicz was chief medical officer at Waltham, MA-based Cerulean Pharma (NASDAQ: [[ticker:CERU]]). His experience includes positions at Ignyta (NASDAQ: [[ticker:RXDX]]), Sanofi Oncology (NYSE: [[ticker:SNY]]), Tokai Pharmaceuticals, and AstraZeneca (NYSE: [[ticker:AZN]]). Senderowicz also worked in the FDA’s Center for Drug Evaluation Research in the division that reviews oncology products.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan